Stock Information

Stock Quote & Chart (TRDA)

Previous Close
Day High
Day Low
52-Week High
52-Week Low

Last Updated: 11 Aug, 2022 9:44 AM EDT Minimum 15 minute delay

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Analyst Coverage

Entrada Therapeutics is followed by the analysts named below

Company Name
Goldman Sachs
Chris Shibutani, MD
Joseph Thome, PhD
Evercore ISI
Umer Raffat and Jonathan Miller, PhD

Entrada Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Entrada Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Entrada Therapeutics or its management. Entrada Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.